Article citationsMore>>

Butler, C. C., Dorward, J., Yu, L. M., Gbinigie, O., Hayward, G., Saville, B. R., Van Hecke, O., Berry, N., Detry, M., Saunders, C., Fitzgerald, M., Harris, V., Patel, M. G., de Lusignan, S., Ogburn, E., Evans, P. H., Thomas, N. P., & Hobbs, F. R. (2021). Azithromycin for Community Treatment of Suspected COVID-19 in People at Increased Risk of an Adverse Clinical Course in the UK (PRINCIPLE): A Randomised, Controlled, Open-Label, Adaptive Platform Trial. The Lancet, 397, 1063-1074.
https://doi.org/10.1016/S0140-6736(21)00461-X

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top